EGFR and cancer: For example, cancer‐derived EVs deliver EGFR and integrin αv into liver stromal cells as discussed above (Hoshino et al., 2015; Zhang et al., 2017), which could contribute to liver toxicity of anti‐EGFR ADCs and anti‐integrin αv ADCs (Figure 4).